Accuray (ARAY) Competitors

Orthofix Medical (NASDAQ:OFIX) and Accuray (NASDAQ:ARAY) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their valuation, institutional ownership, analyst recommendations, media sentiment, community ranking, profitability, earnings, dividends and risk.

Which has more risk and volatility, OFIX or ARAY?

Orthofix Medical has a beta of 0.8, indicating that its stock price is 20% less volatile than the S&P 500. Comparatively, Accuray has a beta of 1.3, indicating that its stock price is 30% more volatile than the S&P 500.

Which has preferable earnings & valuation, OFIX or ARAY?

Accuray has lower revenue, but higher earnings than Orthofix Medical. Accuray is trading at a lower price-to-earnings ratio than Orthofix Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Orthofix Medical	$804.53M	0.55	-$151.40M	-$3.69	-3.08
Accuray	$465.25M	0.28	-$15.55M	-$0.05	-25.00

Is OFIX or ARAY more profitable?

Accuray has a net margin of -0.96% compared to Orthofix Medical's net margin of -15.18%. Accuray's return on equity of -9.75% beat Orthofix Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Orthofix Medical	-15.18%	-21.25%	-13.29%
Accuray	-0.96%	-9.75%	-0.93%

Do insiders and institutionals believe in OFIX or ARAY?

89.8% of Orthofix Medical shares are held by institutional investors. Comparatively, 64.1% of Accuray shares are held by institutional investors. 1.3% of Orthofix Medical shares are held by company insiders. Comparatively, 4.2% of Accuray shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Does the MarketBeat Community prefer OFIX or ARAY?

Orthofix Medical received 80 more outperform votes than Accuray when rated by MarketBeat users. However, 65.50% of users gave Accuray an outperform vote while only 61.93% of users gave Orthofix Medical an outperform vote.

Company	Underperform	Outperform
Orthofix Medical	Outperform Votes 418 61.93%	Underperform Votes 257 38.07%
Accuray	Outperform Votes 338 65.50%	Underperform Votes 178 34.50%

Do analysts prefer OFIX or ARAY?

Orthofix Medical currently has a consensus target price of $23.33, suggesting a potential upside of 105.04%. Given Orthofix Medical's stronger consensus rating and higher possible upside, analysts plainly believe Orthofix Medical is more favorable than Accuray.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Orthofix Medical	0 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.75
Accuray	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Does the media prefer OFIX or ARAY?

In the previous week, Orthofix Medical had 2 more articles in the media than Accuray. MarketBeat recorded 11 mentions for Orthofix Medical and 9 mentions for Accuray. Orthofix Medical's average media sentiment score of 0.54 beat Accuray's score of 0.07 indicating that Orthofix Medical is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Orthofix Medical	4 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Accuray	1 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	4 Negative mention(s)	1 Very Negative mention(s)	Neutral

Summary

Orthofix Medical beats Accuray on 10 of the 18 factors compared between the two stocks.